Skip to main content
Clinical Trials/JPRN-UMIN000005140
JPRN-UMIN000005140
Completed
N/A

Evaluation of efficacy in improvement of cardiac function / renal function by REZALTAS COMBINATION TABLETS on hypertension patient. - Evaluation of efficacy of REZALTAS COMBINATION TABLETS on hypertension patient.

Kanazawa Medical University Hospital0 sites60 target enrollmentMarch 1, 2011
Conditionshypertension

Overview

Phase
N/A
Intervention
Not specified
Conditions
hypertension
Sponsor
Kanazawa Medical University Hospital
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Secondary hypertension 2\)Known history of cerebral apoplexy. 3\)Hyperkalemia (K\>5\.0mEq/L) 4\)Serum Cr\>3\.0mg/dl 5\)Severe hepatic disease. 6\)Woman who are pregnant or woman of childbearing potential. 7\)Patient who has olmesartan allergy or azelnidipine allergy.

Outcomes

Primary Outcomes

Not specified

Similar Trials